Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 65.17M | 14.52M | 16.66M | 18.52M | 71.86M |
| Total Other Revenue | 3.39M | 2.34M | 2.34M | 2.34M | 2.34M |
| Total Revenue | 68.56M | 16.86M | 19.00M | 20.86M | 74.21M |
| Cost of Revenue | 455.04M | 469.53M | 513.30M | 520.95M | 501.87M |
| Gross Profit | -386.49M | -452.67M | -494.30M | -500.09M | -427.66M |
| SG&A Expenses | 92.07M | 95.16M | 98.67M | 106.65M | 119.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 547.12M | 564.68M | 611.97M | 627.60M | 620.90M |
| Operating Income | -478.56M | -547.82M | -592.97M | -606.74M | -546.69M |
| Income Before Tax | -437.77M | -499.39M | -549.95M | -579.05M | -523.11M |
| Income Tax Expenses | 217.00K | 268.00K | 277.00K | -1.41M | -1.15M |
| Earnings from Continuing Operations | -437.99 | -499.65 | -550.23 | -577.65 | -521.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -437.99M | -499.65M | -550.23M | -577.65M | -521.96M |
| EBIT | -478.56M | -547.82M | -592.97M | -606.74M | -546.69M |
| EBITDA | -466.88M | -536.16M | -581.41M | -593.83M | -532.13M |
| EPS Basic | -3.16 | -3.62 | -4.01 | -4.22 | -3.83 |
| Normalized Basic EPS | -1.98 | -2.27 | -2.46 | -2.49 | -2.19 |
| EPS Diluted | -3.16 | -3.62 | -4.01 | -4.22 | -3.83 |
| Normalized Diluted EPS | -1.98 | -2.27 | -2.46 | -2.49 | -2.19 |
| Average Basic Shares Outstanding | 554.07M | 551.66M | 549.38M | 547.16M | 544.97M |
| Average Diluted Shares Outstanding | 554.07M | 551.66M | 549.38M | 547.16M | 544.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |